How brain activity affects the breakdown of a key neuromodulator
Activity-dependent degradation of a neuromodulator
This study is looking at how brain activity affects the breakdown of a natural chemical called 2-AG in a part of the brain that helps control movement and balance, which could help us understand how stress and anxiety might change brain function and behavior.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Health Sciences Center NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-10651741 on NIH RePORTER |
What this research studies
This research investigates how neuronal activity influences the degradation of endocannabinoids, specifically 2-AG, in the cerebellum. By understanding this process, the study aims to uncover how changes in neuromodulator levels can affect neuronal circuits and potentially impact behaviors related to anxiety and stress. The approach involves examining the role of the enzyme Monoacylglycerol lipase (MAGL) in regulating the levels of 2-AG following neuronal activation. This could lead to new insights into how experiences like stress or alcohol use alter neuromodulator dynamics.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing anxiety disorders or related conditions that may benefit from neuromodulator regulation.
Not a fit: Patients with conditions unrelated to neuromodulator function or those not experiencing anxiety-related symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for managing anxiety and other conditions related to neuromodulator imbalances.
How similar studies have performed: Previous research has shown that manipulating the degradation of endocannabinoids can reduce anxiety-like behaviors, indicating potential success for this approach.
Where this research is happening
New Orleans, United States
- Lsu Health Sciences Center — New Orleans, United States (Active)
Researchers
- Principal investigator: Liu, Siqiong June — Lsu Health Sciences Center
- Study coordinator: Liu, Siqiong June
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.